Sorafenib 97%

 
The Company intends to make a positive difference to society and contribute itsshare towards the social cause of betterment of society and area in which companyoperates.The Company also believes in the trusteeship concept.This entailstranscending business interests and working towards making a meaningfuldifference to the society.
We, Cdymax (India) Pharma Private Limited believe that creation of large societalcapital is as important as wealth creation for our shareholders.As a responsiblehuman organization, we are committed towards the above objective and are keenon developing a sustainable business model to ensure and activate our future growthdrivers. In line with the regulatory expectations, we are putting in place a formalpolicy as a guide towards our social commitment going forward.
CDYMAX ensures and adherence to HSE practices.
Our infrastructure for oncology APIs supports capacity of 35MTs plus annually, having line 1 (20MTs) & line 2 (15MTs) separately.
Our General APIs facility has capacity of 200MTs plus annually, with line 1 (110MTs) and Line 2 (90MTs) separately.